Literature DB >> 743490

Influence of anaesthetics on tumour-cell kill and repopulation in B16 melanoma treated with melphalan.

J H Peacock, T C Stephens.   

Abstract

The influence of anaesthetics on the in vivo response of B16 melanoma to melphalan was studied using an in vitro cell-survival assay. Three anaesthetics were used, Saffan (Althesin) Sagatal (Nembutal) and Hypnorm. When Saffan was administered to tumour-bearing animals before melphalan there was a significant increase in tumour-cell kill. This effect was not observed with Sagatal or Hypnorm. Maximum increase in tumour-cell kill was achieved when Saffan was administered about 1 h before melphalan, and was dependent on Saffan dose. Clonogenic tumour-cell repopulation after melphalan was rapid (TD - 1 day) and the rate was similar from 2 levels of cell kill. When Saffan was combined with melphalan the repopulation rate was the same as with melphalan alone, and the increased cell kill was reflected in increased growth delay. The in vitro response of B16 melanoma cells to melphalan was unaltered by pretreatment with, or simultaneous exposure to Saffan. The results suggest that the mechanism of the enhanced cell kill in vivo is probably due to an indirect systemic effect, rather than a direct effect on the tumour cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 743490      PMCID: PMC2009819          DOI: 10.1038/bjc.1978.279

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  6 in total

1.  Reduction of colony-forming cell sensitivity to arabinosylcytosine by halothane anesthesia.

Authors:  D L Bruce; H S Lin; W R Bruce
Journal:  Cancer Res       Date:  1970-06       Impact factor: 12.701

2.  Changes in mouse blood pressure, tumor blood flow, and core and tumor temperatures following nembutal or urethane anesthesia.

Authors:  R Johnson; J F Fowler; G D Zanelli
Journal:  Radiology       Date:  1976-03       Impact factor: 11.105

3.  Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

4.  Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.

Authors:  T C Stephens; J H Peacock
Journal:  Br J Cancer       Date:  1977-09       Impact factor: 7.640

5.  Cell survival in B16 melanoma after treatment with combinations of cytotoxic agents: lack of potentiation.

Authors:  T C Stephens; J H Peacock; G G Steel
Journal:  Br J Cancer       Date:  1977-07       Impact factor: 7.640

6.  A soft agar colony assay for Lewis lung tumour and B16 melanoma taken directly from the mouse.

Authors:  V D Courtenay
Journal:  Br J Cancer       Date:  1976-07       Impact factor: 7.640

  6 in total
  8 in total

1.  The effectiveness of cis-platinum, cyclophosphamide and melphalan in treating disseminated tumor cells in mice.

Authors:  A Kanclerz; J D Chapman
Journal:  Clin Exp Metastasis       Date:  1987-09       Impact factor: 5.150

Review 2.  Can dose-survival parameters be deduced from in situ assays?

Authors:  T E Wheldon
Journal:  Br J Cancer Suppl       Date:  1980-04

3.  Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole.

Authors:  T C Stephens; V D Courtenay; J Mills; J H Peacock; C M Rose; D Spooner
Journal:  Br J Cancer       Date:  1981-04       Impact factor: 7.640

4.  The effect of radiosensitizers on the pharmacokinetics of melphalan and cyclophosphamide in the mouse.

Authors:  M Hinchliffe; N J McNally; M R Stratford
Journal:  Br J Cancer       Date:  1983-09       Impact factor: 7.640

5.  Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse.

Authors:  D J Honess; P Workman; J E Morgan; N M Bleehen
Journal:  Br J Cancer       Date:  1980-04       Impact factor: 7.640

6.  Differential effect of hyperthermia and x-irradiation on regrowth rate and tumour-bed effect for a rat sarcoma.

Authors:  T E Wheldon; E C Hingston
Journal:  Br J Cancer       Date:  1982-02       Impact factor: 7.640

7.  Response of two mouse tumours to hyperthermia with CCNU or melphalan.

Authors:  M C Joiner; G G Steel; T C Stephens
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

8.  Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine.

Authors:  I J Stratford; G E Adams; J Godden; J Nolan; N Howells; N Timpson
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.